Immunovant Inc IMVT
NASDAQ · United States · Health Technology
$33.78+0.32 (+0.96%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q1 2026 | 2026-08-06 | -0.75 | -0.63 | -19.3% | $0 | — | +1.7%$39.28→$39.95 |
| Q4 2026 | 2026-05-20 | -0.67 | -0.63 | -6.3% | — | — | +29.8%$26.29→$34.13 |
| Q3 2026 | 2026-02-06 | -0.54 | -0.69 | +21.7% | — | — | +14.3%$24.06→$27.49 |
| Q3 2025 | 2025-11-10 | -0.73 | -0.72 | -1.4% | — | — | -2.0%$23.35→$22.89 |
| Q4 2025 | 2025-05-29 | -0.64 | -0.72 | +11.1% | — | — | — |
| Q4 2024 | 2024-05-29 | -0.52 | -0.43 | -20.9% | — | — | — |
| Q3 2024 | 2024-02-12 | -0.36 | -0.42 | +14.3% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.